KARIPHARMA
ActiveSummary
KARIPHARMA has been active since 2003 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €632,727 and a net result of €108,353. Equity has been growing by about 4.4% per year since 2018. Its solvency ranks better than 79% of 2,812 sector peers (NACE 82, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Overview
Official details
Source: KBO- Status
- Active since 21-03-2003 Normal situation
- Activity
- Other business support services NACE 82990
- Establishment unit
- 2.355.917.291 1742 Ternat, since 21-03-2003
- Financial year end
- 31 December
- Peppol
- Reachable since 17-09-2025
Board and ownership
Board
- PharmadaDirector · permanent representative Kristel Broechoven
Shareholders
- Pharmada100%2025 annual accounts of Pharmada
- Holdings
- Shares in 1 company APOTHEEK BROECHOVEN
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
Annual accounts 2025
- Gross margin
- €129,534
- Turnover
- ≈ €190,000
- estimated
- Profit
- €108,353
- Equity
- €632,727
- ▲ 0.1%
- Total assets
- €827,778
- ▼ 4.2%
Filed on 17-06-2026, 44 days before the deadline
Score breakdownraises riskLiquidity: current ratio 0.35, cash €41,083, halvedlowers riskSize: total assets €827,778Equity €632,727 (76.4% of total assets)Sector: Office administrative, office support and other business support activities (NACE 82)Show the evidence
Checked score
Score 2025
94
/ 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 55% of micro companies in office administrative support (NACE 82)
Financial strength · tick: 2024
Strong
Solvency
100+2
equity 76.4% of total assets
Liquidity
48-4
short-term debt 23.6% · cash 5.0%
Profitability
85+71
return on assets 13.1%
Bankruptcy probability within 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%lowest value
01-2025: < 0.1%● unchanged vs 12-2024lowest value
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: 0.1%▲ +0.1 percentage points vs 06-2025
08-2025: 0.1%● unchanged vs 07-2025
09-2025: 0.1%● unchanged vs 08-2025
10-2025: 0.1%● unchanged vs 09-2025
11-2025: 0.1%● unchanged vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.1%● unchanged vs 01-2026
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.1%● unchanged vs 04-2026
06-2026: 0.1%● unchanged vs 05-2026
07-2026: 0.1%● unchanged vs 06-2026
08-2026: 0.2%▲ +0.1 percentage points vs 07-2026
09-2026: 0.2%● unchanged vs 08-2026highest value
10-2026: < 0.1%▼ -0.2 percentage points vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €55,000 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.35 (0.39 in 2024), below 1. Short-term debt is 23.6% and cash 5% of total assets. 23.6% of the assets are financed with debt and provisions.
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 82, micro). It does better than 88% of them on solvency, 32% on liquidity, 59% on profitability and 40% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-06-2026, 44 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
44 days early
2024
38 days early
2023
37 days early
2022
32 days early
2021
45 days early
2020
44 days early
2019
on the day
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 34 days before the deadline. In the sector (NACE 82), the median for financial year 2024 was 7 days before the deadline, and 35% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 23 June (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
Financials
Financials · financial year 2025, abbreviated format
Annual accounts 2025 filed on 17-06-2026 at the NBB all 22 filings
Turnover
≈ €190,000
Estimated: probably between €150,000 and €270,000
Total assets
€827,778▼ 4.2%
2024 · €864,466
Net result
€108,353
2024 · -€35,216
Working capital
-€126,780▲ 9.3%
2024 · -€139,797
In the rankings
#8 company by equity in Ternat, Administrative and support services sector#9 oldest company in Ternat, Administrative and support services sector
Trend over the years
2021 to 2025, 5 financial years 2018 to 2025, 8 financial years
The operating result for 2025 is a profit of €112,892, after a loss of €27,317 in 2024.
Operating result€112,892
2025
Net result€108,353
2025
Total assets€827,778
2025
Equity€632,727
2025
Debt€195,051
2025
Working capital-€126,780
2025
Return on assets (ROA)13.1%
2025
Solvency76.4%
2025
Current ratio0.35
2025
Turnover is what the company sold, the result is what was left of it. A loss stands below the zero line.
Assets, equity and debt per financial year.
Above zero, the company can pay its short-term debts with what it holds in the short term.
The EBIT margin is the share of each euro of turnover left from operations. The return on assets is what the assets earn.
The higher the solvency, the better the company absorbs a setback.
A ratio above 1 means the short-term assets cover the short-term debts.
Use the arrow keys on the chart for the figures per year.
The sector band is the middle half of the companies in Office administrative, office support and other business support activities (NACE 82). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30. The dashed line is the median. There is a sector band for net result, equity, total assets, working capital, solvency, current ratio and return on assets (ROA).
Every figure with its change against the financial year before
favourable
unfavourable
Line20182019202020212022202320242025
Operating result€93,987-€83,607▼ 11.0%€73,711▼ 11.8%€73,210▼ 0.7%€121,451▲ 65.9%€123,148▲ 1.4%-€27,317€112,892
Net result€70,321-€59,804▼ 15.0%€51,644within the sector's middle half▼ 13.6%€51,601within the sector's middle half▼ 0.1%€85,827within the sector's middle half▲ 66.3%€82,408within the sector's middle half▼ 4.0%-€35,216below the sector's middle half€108,353above the sector's middle half
Equity€453,689-€513,493▲ 13.2%€565,138within the sector's middle half▲ 10.1%€616,739within the sector's middle half▲ 9.1%€623,583within the sector's middle half▲ 1.1%€667,591within the sector's middle half▲ 7.1%€632,374within the sector's middle half▼ 5.3%€632,727within the sector's middle half▲ 0.1%
Total assets€787,614-€838,824▲ 6.5%€875,148within the sector's middle half▲ 4.3%€917,893within the sector's middle half▲ 4.9%€970,570within the sector's middle half▲ 5.7%€905,440within the sector's middle half▼ 6.7%€864,466within the sector's middle half▼ 4.5%€827,778within the sector's middle half▼ 4.2%
Debt€333,925-€325,331▼ 2.6%€310,011▼ 4.7%€301,154▼ 2.9%€346,988▲ 15.2%€237,849▼ 31.5%€232,091▼ 2.4%€195,051▼ 16.0%
Working capital-€224,395--€164,882▲ 26.5%-€101,573below the sector's middle half▲ 38.4%-€62,314below the sector's middle half▲ 38.7%-€127,015below the sector's middle half▼ 104%-€119,092below the sector's middle half▲ 6.2%-€139,797below the sector's middle half▼ 17.4%-€126,780below the sector's middle half▲ 9.3%
Solvency57.6%-61.2%▲ 3.6pp64.6%within the sector's middle half▲ 3.4pp67.2%within the sector's middle half▲ 2.6pp64.2%within the sector's middle half▼ 2.9pp73.7%above the sector's middle half▲ 9.5pp73.2%above the sector's middle half▼ 0.6pp76.4%above the sector's middle half▲ 3.3pp
Current ratio0.32-0.49▲ 0.170.66below the sector's middle half▲ 0.170.79within the sector's middle half▲ 0.130.63below the sector's middle half▼ 0.160.49below the sector's middle half▼ 0.140.39below the sector's middle half▼ 0.100.35below the sector's middle half▼ 0.04
Return on assets (ROA)8.9%-7.1%▼ 1.8pp5.9%within the sector's middle half▼ 1.2pp5.6%within the sector's middle half▼ 0.3pp8.8%within the sector's middle half▲ 3.2pp9.1%within the sector's middle half▲ 0.3pp-4.1%below the sector's middle half▼ 13.2pp13.1%within the sector's middle half▲ 17.2pp
Staff (FTE)0below the sector's middle half
above
within
below
The sector band is the middle half of the companies in Office administrative, office support and other business support activities (NACE 82). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin are not published. The abbreviated format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €827,778
Fixed assets
€759,507 ▼ 2.0%
Current assets
€68,271 ▼ 23.7%
Equity and liabilities €827,778
Equity
€632,727 ▲ 0.1%
Debt
€195,051 ▼ 16.0%
Debt's share of the balance-sheet total falls from 26.8% to 23.6%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€128,384▲
2024 · -€11,824
Cash flow
€123,845▲
2024 · -€19,724
Debt to equity
0.31▼
2024 · 0.37
ROE
17.1%▲
2024 · -5.6%
Interest coverage
44.00▲
2024 · -1.55
Debt ≤ 1 year
€195,051▼
2024 · €229,263
Income taxes
€2,067▲
2024 · €251
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.
Investments
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Tangible fixed assets | - | €77,464 | - | - | - |
| Financial fixed assets | - | - | €54,000 | - | - |
| Depreciation and write-downs of the year | - | €5,478 | €15,493 | €15,493 | €15,493 |
Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)
Comparable companies
These companies have the same main activity as KARIPHARMA: other business support services (NACE 82990). They are comparable in size and age: total assets between €722,000 and €896,000, founded between 2000 and 2003.
| Company | Founded | Total assets | Equity | Gross margin | Net result | FTE | Financial year |
|---|---|---|---|---|---|---|---|
| KARIPHARMA Ternat | 2003 | €827,778 | €632,727 | €129,534 | €108,353 | - | 2025 |
| GANICOR EUROPE Gent | 2001 | €847,206 | €453,672 | €122,018 | €82,380 | - | 2025 |
| SVP DIENSTENCENTRUM Genk | 2001 | €758,135 | €729,543 | €126,454 | -€72,482 | - | 2025 |
| MOOREA PROJECTS Bree | 2003 | €727,597 | €606,396 | €145,189 | €8,154 | 0.4 | 2025 |
| LIBERO FINANCIAL AND BUSINESS CONSULTANCY Zandhoven | 2000 | €895,809 | €302,714 | €122,210 | €74,503 | 0 | 2025 |
| JOCHAN Kapellen | 2002 | €722,034 | €279,354 | €148,317 | €34,894 | 1 | 2025 |
| EXILE Koksijde | 2002 | €857,054 | €753,880 | €107,858 | €48,151 | - | 2024 |
They were chosen from the 9,746 other active companies with that main activity and annual accounts from the past two years. All companies with this main activity
Annual accounts
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | - | - | €9,898 | €0 | - | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | - | - | - | - | €5,478 | €15,493 | €15,493 | €15,493 | = |
| Other operating charges640/8 | - | - | - | €1,913 | €1,474 | €1,167 | €2,003 | €1,149 | ▼ 42.6% |
| Gross operating margin9900 | €95,452 | €85,617 | €75,466 | €75,123 | €128,403 | €139,808 | -€9,821 | €129,534 | - |
| Operating profit (loss)9901 | €93,987 | €83,607 | €73,711 | €73,210 | €121,451 | €123,148 | -€27,317 | €112,892 | - |
| Financial income75/76B | - | - | - | €0 | - | - | - | €446 | - |
| Recurring financial income75 | €0 | €0 | €0 | €0 | - | - | - | €446 | - |
| Financial charges65/66B | - | - | - | €1,390 | €2,043 | €10,217 | €7,649 | €2,918 | ▼ 61.9% |
| Recurring financial charges65 | €2,880 | €2,344 | €1,869 | €1,390 | €2,043 | €10,217 | €7,649 | €2,918 | ▼ 61.9% |
| Profit (loss) for the period before taxes9903 | €92,764 | €83,196 | €71,842 | €71,819 | €119,408 | €112,931 | -€34,966 | €110,420 | - |
| Income taxes67/77 | €22,443 | €23,392 | €20,197 | €20,218 | €33,581 | €30,523 | €251 | €2,067 | ▲ 725% |
| Profit (loss) for the period9904 | €70,321 | €59,804 | €51,644 | €51,601 | €85,827 | €82,408 | -€35,216 | €108,353 | - |
| Profit (loss) for the period to be appropriated9905 | €70,321 | €59,804 | €51,644 | €51,601 | €85,827 | €82,408 | -€35,216 | €108,353 | - |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total assets20/58 | €787,614 | €838,824 | €875,148 | €917,893 | €970,570 | €905,440 | €864,466 | €827,778 | ▼ 4.2% |
| Fixed assets21/28 | €680,000 | €680,000 | €680,000 | €680,000 | €751,985 | €790,493 | €775,000 | €759,507 | ▼ 2.0% |
| Tangible fixed assets22/27 | - | - | - | - | €71,985 | €56,493 | €41,000 | €25,507 | ▼ 37.8% |
| Furniture and vehicles24 | - | - | - | - | €71,985 | €56,493 | €41,000 | €25,507 | ▼ 37.8% |
| Financial fixed assets28 | €680,000 | €680,000 | €680,000 | €680,000 | €680,000 | €734,000 | €734,000 | €734,000 | = |
| Current assets29/58 | €107,614 | €158,824 | €195,148 | €237,893 | €218,585 | €114,947 | €89,466 | €68,271 | ▼ 23.7% |
| Amounts receivable within one year40/41 | €6,956 | €1,834 | €5,303 | €196 | €4,487 | €3,093 | €3,355 | €26,953 | ▲ 703% |
| Trade receivables40 | - | - | - | - | - | - | €1,915 | €1,852 | ▼ 3.3% |
| Other amounts receivable41 | - | - | - | €196 | €4,487 | €3,093 | €1,439 | €25,101 | ▲ 17× |
| Cash at bank and in hand54/58 | €94,740 | €151,076 | €186,647 | €234,642 | €212,130 | €109,804 | €85,844 | €41,083 | ▼ 52.1% |
| Deferred charges and accrued income490/1 | - | - | - | €3,054 | €1,968 | €2,050 | €267 | €236 | ▼ 11.9% |
| Equity and liabilities | |||||||||
| Total equity and liabilities10/49 | €787,614 | €838,824 | €875,148 | €917,893 | €970,570 | €905,440 | €864,466 | €827,778 | ▼ 4.2% |
| Equity10/15 | €453,689 | €513,493 | €565,138 | €616,739 | €623,583 | €667,591 | €632,374 | €632,727 | ▲ 0.1% |
| Contributions10/11 | €262,700 | €262,700 | - | €262,700 | €262,700 | €262,700 | €262,700 | €262,700 | = |
| Reserves13 | €190,417 | €250,192 | €301,837 | €353,438 | €360,282 | €404,290 | €369,674 | €370,027 | ▲ 0.1% |
| Non-distributable reserves130/1 | - | - | - | €21,809 | €21,809 | €21,809 | €0 | - | - |
| Reserves not available under the articles1311 | - | - | - | €21,809 | €21,809 | €21,809 | €0 | - | - |
| Distributable reserves133 | - | - | - | €331,629 | €338,473 | €382,481 | €369,674 | €370,027 | ▲ 0.1% |
| Profit (loss) carried forward14 | €572 | €601 | €601 | €601 | €601 | €601 | €0 | €0 | - |
| Amounts payable17/49 | €333,925 | €325,331 | €310,011 | €301,154 | €346,988 | €237,849 | €232,091 | €195,051 | ▼ 16.0% |
| Amounts payable within one year42/48 | €332,009 | €323,706 | €296,721 | €300,206 | €345,600 | €234,039 | €229,263 | €195,051 | ▼ 14.9% |
| Trade debts44 | €236 | €445 | €330 | €188 | €467 | €2,648 | €634 | €722 | ▲ 13.8% |
| Suppliers440/4 | - | - | - | €188 | €467 | €2,648 | €634 | €722 | ▲ 13.8% |
| Taxes, remuneration and social security45 | - | - | - | €7,824 | €17,994 | €46,968 | €30,535 | €30,968 | ▲ 1.4% |
| Taxes450/3 | - | - | - | €2,164 | €15,219 | €44,138 | €30,535 | €30,968 | ▲ 1.4% |
| Remuneration and social security454/9 | - | - | - | €5,661 | €2,775 | €2,830 | €0 | - | - |
| Other amounts payable47/48 | - | - | - | €292,194 | €327,139 | €184,423 | €198,094 | €163,362 | ▼ 17.5% |
| Accrued charges and deferred income492/3 | - | - | - | €948 | €1,387 | €3,810 | €2,828 | €0 | ▼ 100% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €70,321 | €59,804 | €51,644 | €51,601 | €85,827 | €82,408 | -€35,216 | €108,353 | - |
| + Depreciation and write-downs630 | - | - | - | - | €5,478 | €15,493 | €15,493 | €15,493 | = |
| Operating cash flow (approximation) | €70,321 | €59,804 | €51,644 | €51,601 | €91,305 | €97,901 | -€19,724 | €123,845 | - |
| Investment in fixed assets (approximation) | - | €0 | €0 | €0 | -€77,464 | -€54,000 | €0 | €0 | - |
| Change in cash | - | €56,336 | €35,571 | €47,995 | -€22,512 | -€102,326 | -€23,960 | -€44,761 | ▼ 86.8% |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Latest 10 of 22 filings with the National Bank
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | abbreviated format | 17-06-2026 | 2026-00168154 | NBB |
| 31-12-2024 | abbreviated format | 23-06-2025 | 2025-00162870 | |
| 31-12-2023 | abbreviated format | 24-06-2024 | 2024-00152724 | |
| 31-12-2022 | abbreviated format | 29-06-2023 | 2023-00187086 | |
| 31-12-2021 | abbreviated format | 16-06-2022 | 2022-20070203 | |
| 31-12-2020 | abbreviated format | 17-06-2021 | 2021-21600252 | |
| 31-12-2019 | abbreviated format | 31-07-2020 | 2020-38100597 | |
| 31-12-2018 | abbreviated format | 19-07-2019 | 2019-35500349 | |
| 31-12-2017 | abbreviated format | 25-06-2018 | 2018-23200192 | |
| 31-12-2016 | abbreviated format | 26-06-2017 | 2017-23000041 |
Board & ownership
Directors
Directors
1 director, last change in 2024
Board 1
Pharmada
Current
Director · appointed in the act of 09-04-2024 · term without a fixed end · Private limited company · permanent representative: Kristel Broechoven · listed in the 2025 annual accounts, filed on 17-06-2026
Permanent representatives 1
Kristel Broechoven
Current
Permanent representative · appointed in the act of 09-04-2024 · for Pharmada
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Artikel 11. Bevoegdheden van het bestuursorgaan Als er slechts één bestuurder is, is het geheel van de bevoegdheden van de bestuurders aan…”
deed of 01-03-2024Owners and capital
Shareholders
1 ownerChain of control
- Pharmada
- KARIPHARMA
Owners 1
- PharmadaparentSourceaccounts Pharmada 2025Equity €169,021 Profit of €83,597 in 2025 (profit of €82,116 in 2024)100%
Mandate history
3 people, 1 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| Pharmada |
|
| An Broechoven |
|
| BROECHOVEN Kristel |
|
Network & group
Holdings and subsidiaries
1 holdingHoldings 1
- APOTHEEK BROECHOVENsubsidiarySourceown accounts 2025Equity €478,279 Profit of €37,246 in 2025 (profit of €147,531 in 2024) Checked score 95100%
Companies at the same address
1 other companyConnections & network
1 current directorThe board mandates are listed under Board mandates elsewhere. The network lets you explore the same ties.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Timeline
Acts, filings and financial milestones
Deadline for the 2026 accounts:
2026
17-06
abbreviated format · 44 days before the deadline
2025
31-12
Financial
Back to profitnet €108,353
The net result is €108,353, after one loss-making year.
23-06
abbreviated format · 38 days before the deadline
2024
31-12
Financial
Weakest financial yearnet -€35,216
The net result drops to -€35,216, the lowest from 2018 to 2025. It recovers the following year.
24-06
abbreviated format · 37 days before the deadline
09-04
Gazette deed
Resignations: An Broechoven (director) and Kristel Broechoven (director)Appointment: BV Pharmada (director) · Permanent representative: Kristel Broechoven · Director discharge8 points ▸
Gazette deed
Resignations: An Broechoven (director) and Kristel Broechoven (director)
Appointment: BV Pharmada (director) · Permanent representative: Kristel Broechoven · Director discharge8 points ▸
- General meeting, 20-12-2023
- Director resignation, An Broechoven (director)
- Director resignation, Kristel Broechoven (director)
- Director discharge, An Broechoven (director)
- Director discharge, Kristel Broechoven (director)
- Other provision, “dank voor diensten, algemene vergadering” (deed in Dutch)
- Director appointment, BV Pharmada (director)
- Permanent representative, Kristel Broechoven
01-03
Gazette deed
Appointment: PHARMADA (director)Permanent representative: BROECHOVEN Kristel · Legal-form conversion · Purpose change11 points ▸
Gazette deed
Appointment: PHARMADA (director)
Permanent representative: BROECHOVEN Kristel · Legal-form conversion · Purpose change11 points ▸
- General meeting, “buitengewone algemene vergadering” (deed in Dutch)
- Legal-form conversion, “besloten vennootschap(BV)” (deed in Dutch)
- Other provision, “verslag bestuursorgaan over voorwerpwijziging, dossier van de notaris” (deed in Dutch)
- Purpose change
- Capital conversion, “artikel 39,§2,tweede lid wet van 2019-03-23, niet-opgevraagde inbrengen” (deed in Dutch)
- Other provision, “opheffing statutair onbeschikbare eigen vermogensrekening, middelen beschikbaar voor uitkering” (deed in Dutch)
- Other provision, “bij uittreksel, voormelde beslissingen” (deed in Dutch)
- Director appointment, PHARMADA (director (not named in the articles))
- Permanent representative, BROECHOVEN Kristel
- Registered office clause, “1742 Ternat,Kerkstraat 14” (deed in Dutch)
- Power of attorney
2023
29-06
abbreviated format · 32 days before the deadline
2022
16-06
abbreviated format · 45 days before the deadline
2021
17-06
abbreviated format · 44 days before the deadline
2020
31-07
abbreviated format · on the deadline day
2019
31-12
Financial
Equity above €500,000equity €513,493 ▲13.2%
With a profit in every financial year since 2018, equity grows to €513,493.
Show earlier events
19-07
abbreviated format · 12 days before the deadline
2018
25-06
abbreviated format · 36 days before the deadline
2017
26-06
abbreviated format · 35 days before the deadline
2003
31-03
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Register details
Identity
KBO recordName
KARIPHARMA in Dutch
Enterprise number
0479.817.428
Legal form
Private limited company
Status
Active, normale toestand
Founded
21-03-2003
Entity type
Legal entity
Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Vlaams Gewest”
deed of 01-03-2024 (in Dutch)Registered office and establishments
Registered office
Kerkstraat 14, 1742 Ternat, Belgium
Establishment unit
KARIPHARMA, Kerkstraat 14, 1742 Ternat since 21-03-2003 · unit number 2.355.917.291
Activities
NACEBEL 202582990
Other business support services main activity
Codes under NACEBEL 2008
82990
Other business support services main activity
Invoicing and payment
VAT number
BE 0479.817.428
Financial year and general meeting
Accounts at the NBBFinancial year end
31-12
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Third Wednesday of June at 17:00
deed of 01-03-2024 (in Dutch)Sites & property
Location
Buildings and parcels at the address
Ground area
329 m²
Building footprint
233 m²
Building volume
1,121 m³
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 23071C0844/00B002 | Flanders | 329 m² | 1 · 233 m² | 9.9 m · 1 |